GIPR and colorectal carcinoma: Regarding the receptor mechanism, the study confirmed the co‐expression of GLP‐1R and GIPR in CRC tissues, and TZP treatment simultaneously activated both receptors, suggesting that its action may involve the coordinated regulation of both receptors signaling pathways.